You searched for
We found 9 articles
Alemtuzumab to Treat Severe Aplastic Anaemia

Alemtuzumab to Treat Severe Aplastic Anaemia

This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath®), in patients with severe aplastic…

01 Jan 2013

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

The purpose of this study is to assess the degree of pain control achieved by treatment with fentanyl, administered via…

01 Jan 2013

An Effectiveness and Safety Study of ‘CONCERTA’ (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder

The purpose of this study is to evaluate the safety and effectiveness of CONCERTA (methylphenidate hydrochloride, a central nervous system…

01 Jan 2013

The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)

The primary objective of this study is to compare, the number of patients with heartburn and regurgitation symptom resolution after…

01 Jan 2013

Safety Study of Oral BTA9881 to Treat Respiratory Syncytial Virus Infections

This is a placebo-controlled, double-blind, randomised, single dose escalation Phase I clinical trial to determine the safety and tolerability of…

01 Jan 2013

Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension

The present trial investigates a possible use of oral bosentan, which is currently approved for the treatment of symptoms of…

01 Jan 2013

BUILD 3: Bosentan Use in Interstitial Lung Disease

BUILD 3: Bosentan Use in Interstitial Lung Disease

BUILD 3 is a prospective, multicenter, randomized, double-blind, parallel group, placebo-controlled, event-driven, group sequential, phase III superiority study. The primary…

01 Jan 2013

SMOOTH – Blood Pressure Control in Diabetic/Obese Patients

The primary objective of the SMOOTH study was to demonstrate that, when combined with hydrochlorothiazide (12.5 mg), telmisartan (80 mg)…

01 Jan 2013

High Density Lipoprotein Turnover

High Density Lipoprotein Turnover

The objective of the study is to evaluate the effect of Rimonabant 20mg in comparison to placebo, on HDL and…

01 Jan 2013